False
Find out how CRISPR genome editing technologies are shaping the future of drug development; we ask experts about the hype versus reality. Also in this issue, patient centricity at Boehringer Ingelheim, real-world data, and why the pharma industry shouldn’t ignore the need for dengue treatments. Academics explain how they have converted plastic waste into pharmaceutical APIs, members of our Power List explore the challenges facing cell and gene therapy, and we invite you to learn more about the importance of crystallization for API manufacturing.
June 13, 2023
Dengue is a deadly, climate-sensitive disease that is spreading rapidly in tropical and subtropical climates worldwide. And because there is no specific cure, we need more investment for research into treatments that can curb the overwhelming pressure placed on healthcare systems.
4 min read
June 12, 2023
Though crystallization is considered a “black art” in some circles, it’s still a crucial part of the API manufacturing process
7 min read
June 7, 2023
Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers
2 min read
May 25, 2023
Need a refresher on biosimilars? Here, we offer some key points to keep in mind when it comes to structure, function, and interchangeability.
5 min read
May 17, 2023
How developments in antivirulence drug treatments could curb the alarming threat of antimicrobial resistance
2 min read
May 12, 2023
Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy
1 min read
May 3, 2023
How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics
9 min read
April 26, 2023
Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is creating a culture of patient-centricity throughout the entire organization.
5 min read
March 15, 2023
How fungi help turn ocean trash into pharmaceutical platform molecules
3 min read
March 9, 2023
As the FDA looks to further integrate real-world data and evidence into clinical research and approval processes, only high-integrity data will do
4 min read
False
